Cyclacel

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 0.000p
  • 52 Week Low: 0.000p
  • Currency: UK Pounds
  • Volume: 0
Digital Look logo and link to homepage

Company Description

Since its formation four years ago, Cyclacel has been developing drug treatments that suppress cancer growth while leaving the normal cells and tissues unharmed.

IPO Details

Issue Date n/a Prospectus n/a
Issue Price n/a Lead Broker Morgan Stanley
Market Cap £83.50m Contact Tel 020 7425 5555
Method Placing    
Sector Pharmaceuticals & Biotech    
Market Main    
Amount Raised £26.00m    

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page